These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38903781)

  • 1. Direct prediction of antimicrobial resistance in
    Cao L; Yang H; Huang Z; Lu C; Chen F; Zhang J; Ye P; Yan J; Zhang H
    Front Microbiol; 2024; 15():1413434. PubMed ID: 38903781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct prediction of carbapenem resistance in
    Liu B; Gao J; Liu XF; Rao G; Luo J; Han P; Hu W; Zhang Z; Zhao Q; Han L; Jiang Z; Zhou M
    J Clin Microbiol; 2023 Nov; 61(11):e0061723. PubMed ID: 37823665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes.
    Madden DE; Baird T; Bell SC; McCarthy KL; Price EP; Sarovich DS
    Genome Med; 2024 Jun; 16(1):78. PubMed ID: 38849863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
    Diorio-Toth L; Irum S; Potter RF; Wallace MA; Arslan M; Munir T; Andleeb S; Burnham CD; Dantas G
    Microbiol Spectr; 2022 Jun; 10(3):e0076622. PubMed ID: 35638817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints.
    Gupta V; Yu KC; Pogue JM; Watts JA; Clancy CJ
    Microbiol Spectr; 2022 Jun; 10(3):e0115822. PubMed ID: 35638777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019.
    Jean SS; Lu MC; Ho MW; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2022 Mar; 59(3):106521. PubMed ID: 35066144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological and molecular studies on a multidrug-resistant Pseudomonas aeruginosa from a liver transplant patient with urinary tract infection in Egypt.
    Shaaban MT; Abdel-Raouf M; Zayed M; Emara MA
    BMC Microbiol; 2024 May; 24(1):184. PubMed ID: 38802754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifactorial resistance mechanisms associated with resistance to ceftazidime-avibactam in clinical
    Babouee Flury B; Bösch A; Gisler V; Egli A; Seiffert SN; Nolte O; Findlay J
    Front Cell Infect Microbiol; 2023; 13():1098944. PubMed ID: 37180441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of mNGS in the Etiological Analysis of Lower Respiratory Tract Infections and the Prediction of Drug Resistance.
    Liu H; Zhang Y; Yang J; Liu Y; Chen J
    Microbiol Spectr; 2022 Feb; 10(1):e0250221. PubMed ID: 35171007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological characteristics of patients with severe burns caused by blast and application of meta- genomics next-generation sequencing in the detection of pathogenic microorganisms].
    Luo RB; Huang M; Hu H; Zhang R; Han CM
    Zhonghua Shao Shang Za Zhi; 2021 Oct; 37(10):946-952. PubMed ID: 34689464
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial and Antibiofilm Effects of Combinatorial Treatment Formulations of Anti-Inflammatory Drugs-Common Antibiotics against Pathogenic Bacteria.
    Tabatabaeifar F; Isaei E; Kalantar-Neyestanaki D; Morones-Ramírez JR
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of antibiotic resistance rates in Pseudomonas aeruginosa isolated in blood cultures in Turkey between 2007 and 2017.
    Isik SA; Yenilmez E; Cetinkaya RA; Gorenek L; Kose S
    North Clin Istanb; 2021; 8(3):286-297. PubMed ID: 34222811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections.
    Serpa PH; Deng X; Abdelghany M; Crawford E; Malcolm K; Caldera S; Fung M; McGeever A; Kalantar KL; Lyden A; Ghale R; Deiss T; Neff N; Miller SA; Doernberg SB; Chiu CY; DeRisi JL; Calfee CS; Langelier CR
    Genome Med; 2022 Jul; 14(1):74. PubMed ID: 35818068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Resistance and Molecular Characterization of Gene Cassettes from Class 1 Integrons in
    Liu M; Ma J; Jia W; Li W
    Microb Drug Resist; 2020 Jun; 26(6):670-676. PubMed ID: 32407190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and Drug Resistance Analysis of Pathogenic Bacteria in Patients with Bacterial Pneumonia in Emergency Intensive Care Unit.
    Yin K; Liu L; Fan G
    Contrast Media Mol Imaging; 2022; 2022():6980091. PubMed ID: 36262997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Clinical mNGS-Based Machine Learning Model for Rapid Antimicrobial Susceptibility Testing of Acinetobacter baumannii.
    Hu X; Zhao Y; Han P; Liu S; Liu W; Mai C; Deng Q; Ren J; Luo J; Chen F; Jia X; Zhang J; Rao G; Gu B
    J Clin Microbiol; 2023 May; 61(5):e0180522. PubMed ID: 37022167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance prediction by clinical metagenomics in pediatric severe pneumonia patients.
    Gan M; Zhang Y; Yan G; Wang Y; Lu G; Wu B; Chen W; Zhou W
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):33. PubMed ID: 38622723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance
    Qader GM; Jarjees KK; Jarjees RK
    J Med Life; 2022 Sep; 15(9):1105-1109. PubMed ID: 36415531
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
    Shortridge D; Pfaller MA; Streit JM; Flamm RK
    J Glob Antimicrob Resist; 2020 Jun; 21():60-64. PubMed ID: 31648032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance survey and whole-genome analysis of nosocomial P. Aeruginosa isolated from eastern Province of China in 2016-2021.
    Hu Z; Zhou L; Tao X; Li P; Zheng X; Zhang W; Tan Z
    Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):12. PubMed ID: 38336730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.